GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Cash And Cash Equivalents

Notable Labs (Notable Labs) Cash And Cash Equivalents : $11.83 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Cash And Cash Equivalents?

Notable Labs's quarterly cash and cash equivalents declined from Dec. 2021 ($2.40 Mil) to Dec. 2022 ($1.58 Mil) but then increased from Dec. 2022 ($1.58 Mil) to Dec. 2023 ($11.83 Mil).

Notable Labs's annual cash and cash equivalents declined from Dec. 2021 ($2.40 Mil) to Dec. 2022 ($1.58 Mil) but then increased from Dec. 2022 ($1.58 Mil) to Dec. 2023 ($11.83 Mil).

Notable Labs Cash And Cash Equivalents Historical Data

The historical data trend for Notable Labs's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Cash And Cash Equivalents Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Cash And Cash Equivalents
2.40 1.58 11.83

Notable Labs Semi-Annual Data
Dec21 Dec22 Dec23
Cash And Cash Equivalents 2.40 1.58 11.83

Notable Labs Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Notable Labs  (NAS:NTBL) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Notable Labs Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Notable Labs's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Notable Labs (Notable Labs) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (NAS:NTBL) » Definitions » Cash And Cash Equivalents
Comparable Companies
NLSP ACST AGE CRBP NBIO CLRB AIM PLUR BIXT SNSE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Website
https://notablelabs.com
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic.